InflaRx stock plummets 84% after failure of skin treatment – MarketWatch

InflaRx stock plummets 84% after failure of skin treatment – MarketWatch

InflaRx stock plummets 84% after failure of skin treatment – MarketWatch
Published on 2019-06-05